FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

423259008: Panitumumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2639908017 Panitumumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2643940012 Panitumumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
370051000195114 panitumumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
193231000077117 panitumumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
2376421000195114 Panitumumab de Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Panitumumab (substance) Is a Epidermal growth factor receptor inhibitor true Inferred relationship Some
Panitumumab (substance) Is a Monoclonal antibody true Inferred relationship Some
Panitumumab (substance) Is a agent d'anticorps monoclonal false Inferred relationship Some
Panitumumab (substance) Is a produit chimique catégorisé selon sa fonction false Inferred relationship Some
Panitumumab (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Epidermal growth factor receptor inhibitor true Inferred relationship Some
Panitumumab (substance) Is a Enzyme inhibitor protein true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing panitumumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Panitumumab (substance) Inferred relationship Some 1
Panitumumab 20mg/mL injection solution 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Panitumumab (substance) Inferred relationship Some
Product containing precisely panitumumab 100 milligram/5 milliliter conventional release solution for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Panitumumab (substance) Inferred relationship Some 1
Product containing precisely panitumumab 100 milligram/5 milliliter conventional release solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Panitumumab (substance) Inferred relationship Some 1
Panitumumab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Panitumumab (substance) Inferred relationship Some 1
Product containing only panitumumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Panitumumab (substance) Inferred relationship Some 1
Panitumumab only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Panitumumab (substance) Inferred relationship Some 1
Product containing precisely panitumumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Panitumumab (substance) Inferred relationship Some 1
Product containing precisely panitumumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Panitumumab (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start